Skip to main content
OpenTrials
Completed

NCT Number: NCT07681700

Effect of Drainage on the Incidence of Seroma After Laparoscopic Trans Abdominal Preperitoneal Inguinal Hernia Repair

The aim of the study is to evaluate the effect of drainage on the incidence of seroma after laparoscopic transabdominal preperitoneal inguinal hernia repair.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University

Cairo, 12613, Egypt

About this study

Inguinal hernia repair is one of the most common surgical conditions encountered in primary care settings. Globally, around 20 million groin hernia repairs are performed each year. Surgical procedure is the gold standard treatment for inguinal hernia repair.

Laparoscopic hernioplasty is suitable for patients with inguinal hernia who can undergo general anesthesia, especially in cases like hernia recurrence after open repair, bilateral hernias, and simultaneous procedures like cholecystectomy.

Although open mesh repair has already demonstrated a low recurrence rate, laparoscopic mesh repair has become increasingly popular in recent years due to its benefits, including a better view of the groin anatomy, ease in addressing bilateral hernias, and superior cosmetic outcomes. The two most widely used laparoscopic mesh repair techniques are Totally Extra peritoneal (TEP) and Trans abdominal Preperitoneal (TAPP) repair, both of which are based on the myopectineal orifice theory. The key difference between TEP and TAPP lies in the method used to access the preperitoneal space.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged from18 to 70 years.
  • Both sexes.
  • Patients were diagnosed with all types of inguinal hernia who are candidates for elective trans-abdominal Preperitoneal (TAPP) repair.

Exclusion criteria

  • Previous history of pelvic or lower abdominal surgery.
  • Coagulopathy.
  • Any condition contraindicating laparoscopic surgery.
  • Patients with complicated hernia (irreducible/incarcerated or obstructed/strangulated hernia).
  • Active infections.
  • Uncorrected medical comorbidities.
  • Bilateral inguinal hernia either preoperative or intraoperative diagnosis.

Treatment and study plan

Trans-abdominal preperitoneal repair + Drainage

Procedure

Patients underwent the trans-abdominal preperitoneal (TAPP) repair technique with closed suction drain was placed through the lateral 5 mm port.

Trans-abdominal preperitoneal repair

Procedure

Patients underwent the trans-abdominal preperitoneal (TAPP) repair technique but the drain wasn't applied.

Primary outcomes

  1. Incidence of patients suffering from Seroma

    Time frame: 6 months post-procedure

    Incidence of patients suffering from Seroma in each group after Transabdominal preperitoneal inguinal hernia repair.

Secondary outcomes

  1. Degree of pain

    Time frame: 24 hours post-procedure

    Pain was assessed using Visual Analogue Scale (VAS) in which the pain score is defined from 0 (no pain) to 10 (maximum pain) at rest and during activity recorded at similar intervals.

  2. Degree of patient satisfaction

    Time frame: 24 hours post-procedure

    Degree of patient satisfaction was assessed using 3-likert point scale where (1, Neutral; 2, Satisfied; 3, Very satisfied)

  3. Measurement of operative time

    Time frame: Till closure of the skin (Up to 60 minutes).

    Measurement of operative time was done from skin incision to closure.

  4. Incidence of recurrence

    Time frame: 6 months post-procedure

    Incidence of recurrence of hernia was assessed during follow-up visits.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Evaluating the Effect of Drainage on the Incidence of Seroma After Laparoscopic Trans Abdominal Preperitoneal Inguinal Hernia Repair

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 2, 2026
Registry last updated
Jul 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.